Distinguished in Bronchiolitis Obliterans

Dr. Michael D. Duncan

Pulmonary Medicine
Healthtexas Provider Network
3410 Worth St, 250 Baylor Scott And White M, 
Dallas, TX 
Distinguished in Bronchiolitis Obliterans
Healthtexas Provider Network
3410 Worth St, 250 Baylor Scott And White M, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Duncan is a Pulmonary Medicine provider in Dallas, Texas. Dr. Duncan is rated as a Distinguished provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Bronchiolitis Obliterans, Industrial Bronchitis, Idiopathic Pulmonary Fibrosis, Bronchitis, and Lung Transplant.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 1 clinical trial in the study of Bronchiolitis Obliterans.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in IN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Sky Community Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER COMMERCIAL
View 2 Less Insurance Carriers -

Locations

HEALTHTEXAS PROVIDER NETWORK
3410 Worth St, 250 Baylor Scott And White M, Dallas, TX 75246

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2025
Intervention Type: Combination product, Other
Study Drug: Extracorporeal Photopheresis (ECP)
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

8 Total Publications

Post lung-transplant predictive value of thermodilution vs estimated Fick cardiac output measurement.
Post lung-transplant predictive value of thermodilution vs estimated Fick cardiac output measurement.
Journal: JHLT open
Published: March 27, 2025
Similar Doctors
Distinguished in Bronchiolitis Obliterans
Dr. Phan T. Nguyen
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Distinguished in Bronchiolitis Obliterans
Dr. Phan T. Nguyen
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
3602 Matlock Rd, Suite 206, 
Arlington, TX 
 (20.8 miles away)
682-323-7006
Languages Spoken:
English, Vietnamese
See accepted insurances
Accepting New Patients

Phan Nguyen is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Arlington, Texas. Dr. Nguyen is rated as a Distinguished provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Bronchiolitis Obliterans, Pleural Effusion, Industrial Bronchitis, Endoscopy, and Advanced Bronchoscopy. Dr. Nguyen is currently accepting new patients.

Distinguished in Bronchiolitis Obliterans
Dr. Muhanned A. Abu-Hijleh
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Distinguished in Bronchiolitis Obliterans
Dr. Muhanned A. Abu-Hijleh
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

University Of Texas Southwestern Medical Center At Dallas

6201 Harry Hines Blvd, 
Dallas, TX 
 (4.6 miles away)
214-645-8300
Languages Spoken:
English
See accepted insurances

Muhanned Abu-Hijleh is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Dallas, Texas. Dr. Abu-Hijleh is rated as a Distinguished provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Tracheobronchomalacia, Lung Nodules, Interstitial Lung Disease, Advanced Bronchoscopy, and Endoscopy.

Advanced in Bronchiolitis Obliterans
Dr. Vaidehi Kaza
Intensive Care Medicine | Pulmonary Medicine
Advanced in Bronchiolitis Obliterans
Dr. Vaidehi Kaza
Intensive Care Medicine | Pulmonary Medicine

University Of Texas Southwestern Medical Center At Dallas

5939 Harry Hines Blvd, 
Dallas, TX 
 (4.3 miles away)
214-645-5505
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Vaidehi Kaza is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Dallas, Texas. Dr. Kaza is rated as a Distinguished provider by MediFind in the treatment of Bronchiolitis Obliterans. Her top areas of expertise are Lung Metastases, Bronchiolitis Obliterans, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Duncan's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile